STAGE III PROSTATE CANCER AJCC V7
Clinical trials for STAGE III PROSTATE CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop prostate cancer from progressing
Disease control OngoingThis study looks at whether adding an experimental drug (MK-2206) to standard hormone therapy (bicalutamide) can better control prostate cancer in men whose PSA levels are rising after initial treatment. About 108 men with recurrent prostate cancer will be randomly assigned to re…
Matched conditions: STAGE III PROSTATE CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Experimental combo aims to starve cancer cells in Late-Stage tumors
Disease control OngoingThis early-phase trial tests the safety and best dose of two drugs—MK-2206 and hydroxychloroquine—given together to people with advanced solid tumors, melanoma, prostate, or kidney cancer. The goal is to see if blocking a process called autophagy can help kill more cancer cells. …
Matched conditions: STAGE III PROSTATE CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC